Amplitude Ventures is a Canadian healthcare venture capital firm based in Montreal that invests in breakthrough life sciences, medical devices, and precision medicine companies. The firm typically targets Series A and Series B rounds, while also supporting company creation through earlier-stage programs.

Its portfolio includes companies such as Prilenia and Fluid Biomed, showing activity across both therapeutics and neurovascular device innovation. Amplitude combines capital with venture-building support and has a strong reputation in the Canadian health innovation ecosystem.

The firm’s primary geographic focus is Canada, with selective activity in the United States. It is relevant for neurotech and precision medicine companies seeking institutional healthcare investors with strong domain knowledge and cross-border scale-up potential.